Medicare Enrolled

Dr. Lisa Smith, DO

Cytopathology Physician · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1122 AUSTIN HWY, San Antonio, TX 78209
2103426488
In practice since 2010 (16 years)
NPI: 1366767378 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Smith from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Smith? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Smith

Dr. Lisa Smith is a cytopathology physician in San Antonio, TX, with 16 years in practice. Based on federal Medicare data, Dr. Smith performed 1,726 Medicare services across 1,096 unique beneficiaries.

Between the years covered by Open Payments, Dr. Smith received a total of $382 from 8 pharmaceutical and/or device companies across 18 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cytopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Smith is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 30% volume in TX$ $382 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,726
Medicare services
Top 30% in TX for cytopathology physician
1,096
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~108 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Tissue staining for diagnosis, additional496$21$100
Tissue staining for diagnosis, initial423$26$170
Pathology examination of tissue using a microscope, moderately high complexity178$62$380
Cell examination of specimen, selective cellular enhancement technique100$20$220
Pathology examination of tissue using a microscope, moderately low complexity82$8$190
Pathology examination of specimen during surgery, first tissue block76$47$250
Special stained specimen slides to identify organisms including interpretation and report47$20$90
Tissue pathology examination, moderate complexity46$28$290
Preparation of tissue for examination by removing any calcium present45$9$50
Special stained specimen slides to examine tissue including interpretation and report45$9$62
Pathology examination of tissue using a microscope, high complexity40$107$470
Microscopic genetic analysis of tumor, manual40$32$210
Evaluation of fine needle aspirate36$26$120
Evaluation of fine needle aspirate with interpretation and report29$53$270
Pathology examination of tissue using a microscope15$4$110
Blood smear interpretation by physician with written report14$18$60
Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method14$124$750
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.4% high complexity
0.8% medium
94.8% routine

Industry Payment Transparency

Open Payments through 2023 ↗
$382
Total received (2018-2023)
Avg $95/year across 4 years
Top 20% in TX for cytopathology physician
8
Companies
18
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$382 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$22
2021
$18
2019
$274
2018
$67

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$144
Amgen Inc.
$77
TerSera Therapeutics LLC
$52
Roche Diagnostics Corporation
$40
Eisai Inc.
$20
Celgene Corporation
$19
EISAI INC.
$17
Novartis Pharmaceuticals Corporation
$12
Top 3 companies account for 71.4% of total payments
Associated products mentioned in payments ›
Kyprolis · Lenvima · Neulasta · Revlimid · TAGRISSO · VENTANA ANTI-MLH1 (M1) Mouse Monoclonal Primary Antibody · VOTRIENT · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $22 per 100 Medicare services performed
Looking for a cytopathology physician in San Antonio?
Compare cytopathology physicians in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse cytopathology physicians nearby

Geographic Context

Cytopathology Physicians within 10 mi
20
Per 100K population
1.0
County median income
$70,571
Nearest hospital
Brooke Army Medical Center (FT Sam Houston)
2.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2023
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Smith is a mixed practice specialist, with above-average Medicare volume (top 30% in TX), and high industry engagement (low-engagement, top 20%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Smith experienced with tissue staining for diagnosis, additional?
Based on Medicare claims data, Dr. Smith performed 496 tissue staining for diagnosis, additional services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Smith receive payments from pharmaceutical companies?
Yes. Dr. Smith received a total of $382 from 8 companies across 18 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Smith's costs compare to other cytopathology physicians in San Antonio?
Dr. Smith's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Smith) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →